Sigma-Genosys Enters Agreement With Novatia
Sigma-Genosys, a division of Sigma-Aldrich has incorporated into its quality control (QC) lab an LC-MS system from Novatia. The system improves the molecular weight determination of larger synthetic oligonucleotides (>50 bases) as well as synthetic peptides. Novatia specializes in developing an integrated system encompassing hardware, software, method development and automated data analysis.
Traditionally, larger synthetic oligonucleotides are analyzed by capillary electrophoresis and by PAGE analysis. When molecular weight information is needed, MALDI-TOF mass analysis is carried out. Traditional MALDI-TOF MS analysis while rapid (<5 seconds per sample) and relatively simple, provides inadequate mass spectra data if any, for larger oligonucleotides. This is due primarily to poor ionization of the large oligonucleotides.
With the integrated Novatia LC-MS system, Sigma-Genosys is able to obtain high quality mass analysis of larger oligonucleotides. Traditional LC-MS techniques can be time consuming and not amenable to high throughput analysis.
The LC-MS system by Novatia along with their methods and their automated post-analysis software provides Sigma-Genosys with a high throughput (one sample per minute) LC-MS technique for the analyses of larger oligonucleotides. The well-integrated instrument and protocols developed by Novatia reduced the IOQ (installation/operating qualification) time to days from the weeks normally associated with high-technology analytical systems.
The Novatia system also provides Sigma-Genosys with the ability to obtain higher quality mass spectra data in a high throughput format. The improved resolution obtained by LC-MS provides more accurate molecular weight of the larger oligonucleotides. This allows detection of base substitutions as well as being able to determine the presence and identification of potential contaminates and base deletions.
Most read news
Topics
Organizations
Other news from the department business & finance
These products might interest you
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Last viewed contents
New chemical imaging technique could help in the fight against atherosclerosis, suggests research
Sticking sugar to protein - Researchers clarified the 3D structure of an important enzyme that links sugar to proteins – a breakthrough
Cancer control: Structure of important transport protein solved - Discovery of promising binding site
How solid-state batteries degrade - What happens during operation?
Xantos Biomedicine and QIAGEN AnnounceCo-Marketing Agreement for RNAi Library with High-Content Cellular Screening System
Closing in on mystery surrounding dangerous blood syndromes - Genetically driven MDS enabled by gene linked to metabolism and oxygen in cells
Long-COVID - all a question of genes? - New study results show possible risk factor
Beckman Coulter and Fujirebio enter into partnership - The goal is a patient-friendly, blood-based Alzheimer's disease test
Beta cells from stem cells: Potential for cell replacement therapy - Quality control with CD177 can help save lots of time, efforts and money
Clinical Reference Laboratory Inc to build European laboratory hub in UK